Showing 941-950 of 1236 results for "".
- Highlights From IMCAS World Congress 2024: 25 years at the Forefront of Medical Aesthetics and Countinghttps://modernaesthetics.com/news/highlights-from-imcas-world-congress-2024-25-years-at-the-forefront-of-medical-aesthetics-and-counting-1/2473561/As a veteran of the International Master Course on Aging Science (IMCAS) for over two decades, IMCAS 2024 was the largest congress to date with over 18,000 attendees in the Palais des Congres. Located in central Paris, we had to navigate a construction zone as workmen were busy getting the city r
- Revision Skincare, RVL Pharmaceuticals Form Partnershiphttps://modernaesthetics.com/news/revision-skincare-rvl-pharmaceuticals-form-partnership/2473288/Revision Skincare® is partnering with RVL Pharmaceuticals, Inc. the owner of UPNEEQ®, to collaborate on a variety of marketing efforts within the medical aesthetics industry, working together to address significant unmet consumer needs. Revisions says that, with shared
- Survey Finds Muscle Maintenance Gaps Among Medical Weight Loss Usershttps://modernaesthetics.com/news/survey-finds-muscle-maintenance-gaps-among-medical-weight-loss-users/2473714/BTL Aesthetics released insights from a recent survey conducted by NewBeauty uncovering the key challenges faced by medical weight loss patients when it comes to muscle maintenance and facial aesthetics. The survey including nearly 2,000 participants from the United States and hig
- Nordic Pharma Welcomes John P. Fezza, MD, to Medical Advisory Boardhttps://modernaesthetics.com/news/nordic-pharma-welcomes-john-fezza-md-to-medical-advisory-board/2473554/Nordic Pharma, Inc., has announced the appointment of renowned oculoplastic surgeon Dr. John P. Fezza, MD, to its U.S. Medical Advisory Board (MAB), according to a press release. The appointment comes as Nordic Pharma prepares to introduce LACRIFILL® Canalicular Gel, a groundb
- Industry Vet Matthew Hill Named CFO at Apyx Medical Corporationhttps://modernaesthetics.com/news/industry-vet-matthew-hill-named-cfo-at-apyx-medical-corporation/2473534/Matthew Hill is Apyx Medical Corporation’s (new Chief Financial Officer (CFO), effective December 4, 2023. Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023. “With its innovative Renuvion technology, large, global m
- Acclaro Medical Rolls Our Rebranded UltraClear Cold Fiber Laserhttps://modernaesthetics.com/news/acclaro-medical-rolls-our-rebranded-ultraclear-cold-fiber-laser/2473448/Meet the newly re-branded UltraClear Cold Fiber Laser from Acclaro Medical. From a design perspective, rebranding encompasses an updated logo and color palette and aims to increase recognition of UltraClear's 3DIntelliPulse technology and its ability to provide optima
- FDA Clears Apyx Medical’s Renuvion Handpiece for Improving Lax Skinhttps://modernaesthetics.com/news/fda-clears-apyx-medicals-renuvion-handpiece-for-improving-lax-skin/2473268/The U.S. Food and Drug Administration received 510(k) clearance for the use of Apyx Medical’s Renuvion APR Handpiece for certain skin contraction procedures. Specifically, the Renuvion APR Handpieces are now indicated for use in subcutaneous dermatological and aest
- Apyx Medical Corporation Scores FDA 510(k) Clearance for Renuvion Handpiecehttps://modernaesthetics.com/news/apyx-medical-corporation-scores-fda-510k-clearance-for-renuvion-handpiece/2473245/The U.S. Food and Drug Administration has granted marketing clearance to Apyx Medical Corporation’s Renuvion Dermal Handpiece for specific dermal resurfacing procedures. The Renuvion Dermal Handpiece is indicated for dermatological procedures for the treatment of moderate to
- Sofwave Medical Goes Public on the Tel Aviv Stock Exchange, Raises $50Mhttps://modernaesthetics.com/news/sofwave-medical-goes-public-on-the-tel-aviv-stock-exchange-raises-50m/2473109/Sofwave Medical made its initial public offering (IPO) on the Tel Aviv Stock Exchange (TASE) and raised $50 million at a pre-money valuation of ~$200 million. The IPO was led by Barak Capital Underwriters. The company has developed Synchronous Ul
- Allergan CEO Calls for Consensus on Medical Aesthetic Treatment in Minorshttps://modernaesthetics.com/news/allergan-ceo-calls-for-consensus-on-medical-aesthetic-treatment-in-minors/2472213/Allergan Chairman & CEO Brent Saunders, the father of two high school-aged girls, is speaking up and out about the risks associated with offering medical aesthetic treatments to minors. In a new blog post, he writes “we must remember that anyone under the age of 18 is still matu